乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

AAD Expert Video Roundtable

<乌鸦传媒 class="page-description">Expert Video Roundtable from the American Academy of Dermatology
Oral Roflumilast Effective in the Treatment of Plaque Psoriasis

Experts discuss the safety and tolerability of this PDE4 inhibitor in a roundtable discussion

image
<乌鸦传媒 class="section_title">Latest AAD Expert Video Roundtable Meeting Coverage
Orismilast Clears Skin in Moderate-to-Severe Psoriasis

Experts at AAD discuss the efficacy and safety of the PDE4 inhibitor in a roundtable discussion

March 27, 2023
Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis

Experts at AAD discuss the efficacy and safety of risankizumab in a roundtable discussion

March 23, 2023
Trial of Novel TYK2 Inhibitor Hits Its Endpoint in Plaque Psoriasis

Experts at AAD discuss the results of the phase IIb study in a roundtable discussion

March 21, 2023
Preventing the Onset of PsA in Patients With Psoriasis

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

May 5, 2022
Oral TYK2 Inhibitor in Plaque Psoriasis

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

April 28, 2022
Bimekizumab Shows Promise in Moderate to Severe Plaque Psoriasis

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

April 21, 2022
Cardiovascular Risk in Patients With Psoriasis

Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD

April 14, 2022
<乌鸦传媒 class="section_title"> Latest Dermatology Meeting Coverage